Inter-Magnification Gene-Expression Strategy

• Inter-Magnification Gene-Expression Consistency Strategy is defined as methods that harmonize multiple magnification views to yield coherent gene-expression estimates from histopathological images.
• It employs multi-scale instance embedding, cross-magnification self-attention fusion, and cosine similarity regularization to bridge the modality gap between tissue morphology and molecular data.
• Empirical studies using frameworks like MMAP, Gene-DML, CHRep, and MERGE demonstrate improved prediction robustness and accuracy in spatial transcriptomics through structure-preserving regularization and prototype enrichment.

Searching arXiv for the specified papers to ground the article and confirm metadata. I’m checking arXiv entries for (Song et al., 19 Jul 2025, Nguyen et al., 13 Oct 2025, Wang et al., 23 Apr 2026), and (Ganguly et al., 2024). Inter-Magnification Gene-Expression Consistency Strategy denotes a class of methods for spatial transcriptomics prediction from histopathology in which co-localized image views extracted at different magnifications, fields of view, or spatial scales are constrained to yield harmonized latent representations and compatible gene-expression estimates. In the literature summarized here, the idea appears explicitly in multi-magnification architectures and implicitly in scale-aware cross-modal alignment, prototype or group regularization, topology-preserving representation learning, and hierarchical graph construction. MMAP formulates the strategy most directly through multi-magnification fusion and cosine-similarity regularization; Gene-DML provides an analogous scale-consistency mechanism through local, neighbor, and global discrimination; CHRep contributes topology-aware alignment and post-hoc calibration under domain shift; and MERGE supplies a graph-theoretic basis for extending consistency across scales and locations (Nguyen et al., 13 Oct 2025, Song et al., 19 Jul 2025, Wang et al., 23 Apr 2026, Ganguly et al., 2024).

1. Problem formulation and conceptual scope

The underlying prediction task is spatial gene-expression regression from hematoxylin and eosin whole-slide images. In MMAP, the input is an H&E-stained whole-slide image $X_i \in [0,255]^{h \times w}$, partitioned into non-overlapping patches $\{P_{ij}\}_{j=1}^{N_i}$ centered at spot coordinates $C_{ij}$, and the output is a per-spot vector $Y_{ij} \in \mathbb{R}^g$, where $g$ is the number of genes; the objective is to learn $\hat{Y}_{ij} = \mathcal{F}_\theta(P_{ij}, C_{ij})$ such that $\hat{Y}_{ij}$ approximates $Y_{ij}$ (Nguyen et al., 13 Oct 2025). CHRep uses the same general setting, with input per spot consisting of an H&E patch $\mathbf{x}_i$, a coordinate $\mathbf{p}_i$, and a gene-expression vector $\{P_{ij}\}_{j=1}^{N_i}$0, and evaluates under leave-one-slide-out conditions to expose cross-slide robustness requirements (Wang et al., 23 Apr 2026).

A central difficulty is the modality gap between visual morphology and molecular expression. MMAP states that fine-grained morphological signals are often only visible at higher magnifications, whereas global tissue context at lower magnifications influences gene expression. CHRep highlights an analogous robustness problem under slide-level appearance shifts: differences in staining, preparation, scanner, and tissue morphology perturb visual features and degrade patch-to-expression mappings. The same logic extends to magnification changes, because magnification alters texture scale, cell density, and the effective context range seen by the model (Nguyen et al., 13 Oct 2025, Wang et al., 23 Apr 2026).

Within this context, an inter-magnification strategy seeks to enforce that views of the same physical location, whether represented as explicit 5×/10×/20× crops or as local/neighbor/global contexts, map to a consistent expression-relevant latent geometry. Gene-DML makes this point indirectly: although it is formulated in terms of local, neighbor, and global scales rather than microscope magnifications, its mechanisms are described as directly applicable to inter-magnification consistency (Song et al., 19 Jul 2025). MERGE, while trained at a single magnification, frames the broader issue as one of preserving coherent interactions across locations and scales, which provides a natural foundation for multi-magnification extensions (Ganguly et al., 2024).

2. Feature-level consistency across magnifications and scales

Gene-DML implements feature-level consistency through a multi-scale instance-level discrimination pathway. Each spatial spot $\{P_{ij}\}_{j=1}^{N_i}$1 is associated with three image contexts: a local patch of $\{P_{ij}\}_{j=1}^{N_i}$2 pixels, a neighbor region of $\{P_{ij}\}_{j=1}^{N_i}$3 pixels, and a global representation formed by applying a Transformer over local-scale features across the whole slide. These yield image instance embeddings $\{P_{ij}\}_{j=1}^{N_i}$4, $\{P_{ij}\}_{j=1}^{N_i}$5, and $\{P_{ij}\}_{j=1}^{N_i}$6, while the gene vector $\{P_{ij}\}_{j=1}^{N_i}$7 is mapped to a gene embedding $\{P_{ij}\}_{j=1}^{N_i}$8 through a small fully connected encoder. The three image scales are then fused by self-attention into

$\{P_{ij}\}_{j=1}^{N_i}$9

The associated loss is scale-specific and neighborhood-weighted: for each scale $C_{ij}$0, Gene-DML constructs an internal similarity matrix

$C_{ij}$1

and uses it inside a symmetric contrastive objective $C_{ij}$2. This treats semantically similar spots as soft positives rather than harsh negatives and aligns every scale-specific image embedding for spot $C_{ij}$3 with the same gene embedding $C_{ij}$4 (Song et al., 19 Jul 2025).

MMAP instantiates the same principle with explicit multi-magnification views. For each base patch $C_{ij}$5, it generates two higher-resolution sub-patches $C_{ij}$6 and $C_{ij}$7, which roughly correspond to $C_{ij}$8 and $C_{ij}$9, then resizes all views back to $Y_{ij} \in \mathbb{R}^g$0. A single UNI encoder with LoRA fine-tuning produces magnification-specific embeddings $Y_{ij} \in \mathbb{R}^g$1. MMAP then forms a fused representation $Y_{ij} \in \mathbb{R}^g$2 by applying self-attention in which the base-magnification [CLS] token attends to tokens from higher magnifications. Stage 1 training combines a regression term with an explicit magnification consistency term,

$Y_{ij} \in \mathbb{R}^g$3

This directly aligns the fused multi-magnification representation with the base-magnification embedding and therefore operationalizes inter-magnification latent consistency (Nguyen et al., 13 Oct 2025).

Taken together, these formulations define the core feature-level pattern: a shared encoder or shared latent space, multiple scale-specific or magnification-specific views per spot, and a regularizer that forces those views to remain expression-compatible. In Gene-DML this is expressed as multi-scale cross-modal correspondence; in MMAP it is expressed as cross-magnification attention followed by cosine alignment (Song et al., 19 Jul 2025, Nguyen et al., 13 Oct 2025).

3. Structural consistency: groups, topology, and graphs

Feature-level agreement alone does not determine how representations should be organized globally. Gene-DML therefore adds a cross-level instance-group discrimination pathway. Image and gene instance embeddings are projected to group embeddings,

$Y_{ij} \in \mathbb{R}^g$4

normalized, and clustered independently with K-means to obtain image centroids $Y_{ij} \in \mathbb{R}^g$5 and gene centroids $Y_{ij} \in \mathbb{R}^g$6. The cross-level loss $Y_{ij} \in \mathbb{R}^g$7 aligns each image instance to gene-group centroids and each gene instance to image-group centroids through soft assignment distributions. The reported effect is to prevent over-separation, preserve higher-level semantic structure, and improve robustness to noise and domain shift by anchoring instances to group-level semantics rather than purely local pairwise similarities (Song et al., 19 Jul 2025).

CHRep addresses structural consistency through topology preservation. During training, histology features $Y_{ij} \in \mathbb{R}^g$8, coordinate features $Y_{ij} \in \mathbb{R}^g$9, and gene features $g$0 are combined into a coordinate-guided morphology representation $g$1, and the model jointly optimizes correlation-aware regression, symmetric image-expression alignment, and coordinate-induced spatial topology regularization. The topology prior is defined as

$g$2

where $g$3 are $g$4-hop adjacency matrices derived from a coordinate-space k-NN graph, and the topology loss is

$g$5

Because the same paper explicitly proposes adapting this construction to within-scale and cross-scale adjacency, it supplies a direct route to multi-magnification topology preservation: patches at different magnifications that cover overlapping regions can be linked in a combined prior so that gene and image embeddings preserve cross-scale neighborhood structure (Wang et al., 23 Apr 2026).

MERGE supplies a graph-based counterpart to these structural ideas. It constructs a multi-faceted hierarchical graph over spot nodes by combining spatial clustering, feature-space clustering, intra-cluster edges linking nodes to centroid spots, shortcut edges among centroids, and 1-hop spatial proximity edges. The resulting topology guarantees that any node can connect to any other node in at most three hops: node $g$6 centroid $g$7 centroid $g$8 node. The same paper then outlines an explicit extension to multi-magnification settings: treat each magnification as a graph layer, add cross-layer edges linking corresponding tissue locations such as

$g$9

and impose

$\hat{Y}_{ij} = \mathcal{F}_\theta(P_{ij}, C_{ij})$0

This extension makes the graph itself the carrier of inter-magnification consistency, rather than only the loss (Ganguly et al., 2024).

These three lines of work converge on the same principle: inter-magnification consistency is not merely pairwise alignment between one low-power and one high-power view. It also requires preservation of group structure, tissue topology, and multi-hop interactions across spatial scales (Song et al., 19 Jul 2025, Wang et al., 23 Apr 2026, Ganguly et al., 2024).

4. Prediction fusion, prototypes, and calibration

MMAP extends magnification consistency from feature learning to prediction fusion. After Stage 1, it performs K-means clustering over fused patch embeddings $\hat{Y}_{ij} = \mathcal{F}_\theta(P_{ij}, C_{ij})$1 within each slide to obtain global prototypes $\hat{Y}_{ij} = \mathcal{F}_\theta(P_{ij}, C_{ij})$2. For each patch, it retrieves the top-$\hat{Y}_{ij} = \mathcal{F}_\theta(P_{ij}, C_{ij})$3 most similar prototypes $\hat{Y}_{ij} = \mathcal{F}_\theta(P_{ij}, C_{ij})$4 and applies cross-attention to produce a global-context enriched representation $\hat{Y}_{ij} = \mathcal{F}_\theta(P_{ij}, C_{ij})$5. Final prediction averages three streams: $\hat{Y}_{ij} = \mathcal{F}_\theta(P_{ij}, C_{ij})$6 where the three terms come from one magnification-specific embedding, the fused multi-magnification embedding, and the prototype-enriched embedding, respectively. Stage 2 imposes an additional consistency loss,

$\hat{Y}_{ij} = \mathcal{F}_\theta(P_{ij}, C_{ij})$7

so that adding global prototype context does not radically alter the local multi-magnification representation (Nguyen et al., 13 Oct 2025).

CHRep addresses the same problem from an inference-time perspective. After training a topology-preserving, cross-modal representation, it freezes the image encoder and builds a training-gallery bank of histology embeddings $\hat{Y}_{ij} = \mathcal{F}_\theta(P_{ij}, C_{ij})$8 and standardized expression vectors $\hat{Y}_{ij} = \mathcal{F}_\theta(P_{ij}, C_{ij})$9. For a query spot, it retrieves top-$\hat{Y}_{ij}$0 neighbors by cosine similarity, forms a similarity-weighted non-parametric estimate

$\hat{Y}_{ij}$1

and then adds a residual correction $\hat{Y}_{ij}$2 to obtain

$\hat{Y}_{ij}$3

The correction is regularized by

$\hat{Y}_{ij}$4

which constrains magnitude and prevents over-correction. The same formulation is proposed as adaptable to magnification-aware galleries and magnification-aware correctors, so that retrieval can draw neighbors across magnifications and the correction branch can compensate only small systematic scale-dependent bias (Wang et al., 23 Apr 2026).

Both papers also describe more explicit formulations of prediction-level inter-magnification consistency. MMAP proposes per-magnification heads

$\hat{Y}_{ij}$5

together with a prediction agreement term

$\hat{Y}_{ij}$6

and a prototype-assignment consistency term defined through magnification-specific prototype probabilities $\hat{Y}_{ij}$7 (Nguyen et al., 13 Oct 2025). CHRep similarly suggests explicit constraints such as

$\hat{Y}_{ij}$8

or encouraging high PCC between predictions at different magnifications of the same region (Wang et al., 23 Apr 2026). These are presented as extensions rather than established components, but they clarify what a fully explicit inter-magnification strategy would require.

5. Empirical evidence

The reported empirical record supports the claim that consistency mechanisms improve gene-expression prediction, although each paper evaluates a different cohort and protocol.

Framework	Reported evidence	Consistency-relevant reading
Gene-DML	On skinST, full Gene-DML reaches PCC(A)=0.433 and PCC(H)=0.520; on HER2ST, PCC(H)=0.541	Combined scale-aware instance alignment and instance-group structure yields the largest gain
MMAP	On HER2+ data, PCC 0.2619 vs HisToGene 0.0753; MSE 1.2439 vs best baseline 1.2822; MAE 0.8873 vs best baseline 0.9396	Multi-magnification encoding plus prototypes improves regression and correlation
CHRep	On Alex+10x, PCC(ACG) 0.2718 vs 0.1949 for mclSTExp, with MSE 0.2102 and MAE 0.3545	Topology-aware learning plus calibration improves robustness under strong shift
MERGE	Hierarchical graph reaches MSE $\hat{Y}_{ij}$9, MAE $Y_{ij}$0, PCC $Y_{ij}$1	Hierarchical spatial-morphological interaction yields more coherent expression maps

Gene-DML provides the clearest ablation evidence on scale and structure. Removing both multi-scale instance-level and instance-group discrimination gives the worst performance. Using only multi-scale instance-level discrimination improves skinST PCC(A) from 0.269 to 0.308. Using only instance-group discrimination improves skinST PCC(H) from 0.396 to 0.478. Using both together yields the best reported values, including a gain of $Y_{ij}$2 PCC(A) and $Y_{ij}$3 PCC(H) versus the plain bimodal baseline on skinST. The paper also reports strong cross-dataset generalization to unseen 10x Visium samples with state-of-the-art PCC(A) and PCC(H), especially for highly predictive genes (Song et al., 19 Jul 2025).

MMAP reports overall improvements on HER2+ breast cancer ST data: PCC 0.2619 versus 0.0753 for HisToGene, MSE 1.2439 versus 1.2822 for the best baseline DeepPT, and MAE 0.8873 versus 0.9396 for the best baseline TCGN. Its ablations indicate that plain cross-attention yields the best PCC and the lowest MSE and MAE for prototype aggregation, while adaptive prototype selection $Y_{ij}$4 gives higher PCC and lower errors than fixed $Y_{ij}$5 (Nguyen et al., 13 Oct 2025).

CHRep demonstrates that robustness-oriented consistency mechanisms can materially improve correlation under leave-one-slide-out evaluation. Relative to HAGE, PCC(ACG) increases by approximately 4.0% on cSCC and 9.8% on HER2+. Relative to mclSTExp, Alex+10x shows a 39.5% improvement in PCC(ACG), together with 9.7% and 9.0% reductions in MSE and MAE, respectively. The calibration ablation on Alex+10x further shows Estimate-only at PCC(ACG) 0.2079, Correction-only at 0.2434, and Estimate+Correction with constraint at 0.2676, with MSE 0.2150 and MAE 0.3551 (Wang et al., 23 Apr 2026).

MERGE shows that coherent multi-location integration is itself a strong predictor of better expression estimates. Against ResNetSimCLR and a 1-hop GNN, the hierarchical graph improves all three metrics, reaching $Y_{ij}$6 MSE, $Y_{ij}$7 MAE, and $Y_{ij}$8 PCC. Ablations indicate that using both spatial and feature clustering is better than using either alone, and that performance improves with cluster size up to approximately 100 spots per cluster before degrading (Ganguly et al., 2024).

6. Limitations and open research directions

The current literature does not treat inter-magnification consistency in a uniform way. Gene-DML is formulated around local, neighbor, and global scales rather than explicit 10×, 20×, and 40× lens magnifications, even though the paper states that the mechanism is directly applicable to inter-magnification settings. A plausible implication is that scale-consistency and magnification-consistency are closely related but not identical design problems: one is defined by context radius, the other by acquisition resolution and crop geometry (Song et al., 19 Jul 2025).

MMAP identifies several concrete limitations. Its magnification scheme is approximate, using 5×, 10×, and 20× views generated by cropping and resizing rather than true multi-resolution whole-slide imagery. Random cropping can miss critical regions. The consistency losses $Y_{ij}$9 and $\mathbf{x}_i$0 align only specific pairs—$\mathbf{x}_i$1 with $\mathbf{x}_i$2, and $\mathbf{x}_i$3 with $\mathbf{x}_i$4—rather than all magnification pairs or all prediction heads. The architecture is not scale-equivariant by design, and per-slide prototype construction may not generalize across slides or scanners (Nguyen et al., 13 Oct 2025).

CHRep also leaves important open questions for multi-magnification deployment. It does not explicitly model magnification variation; its topology is defined in coordinate space rather than in hierarchical tissue structure; and its calibration stage operates on frozen image features, which is robust but may limit adaptation to very different magnifications. The paper further notes a magnitude-versus-correlation trade-off: on HER2+, CHRep improves PCC but not MSE or MAE relative to HAGE (Wang et al., 23 Apr 2026).

MERGE’s limitations are complementary. All experiments are conducted at $\mathbf{x}_i$5 on the ST-Net breast cancer Visium dataset, so multi-magnification performance is untested. Graph construction depends on cluster size and centroid selection, and the method remains sensitive to ST data quality, smoothing parameters, and the chosen gene subset. The paper nevertheless outlines several relevant extensions: multi-layer multi-faceted graphs, scale-aware attention, explicit consistency losses between magnifications, and gene-aware smoothing across magnifications (Ganguly et al., 2024).

Across these works, the recurring future directions are explicit cross-magnification contrastive objectives, scale-equivariant or scale-aware networks, cross-slide or cross-magnification prototype sharing, magnification-aware calibration, and multi-layer graphs with within-scale and cross-scale adjacency. This suggests that the mature form of an inter-magnification gene-expression consistency strategy will likely combine four elements: shared or aligned multi-scale encoders, structure-preserving regularization, prediction-level agreement across views, and a calibration mechanism that corrects magnification-dependent bias without destabilizing the learned biological manifold (Nguyen et al., 13 Oct 2025, Wang et al., 23 Apr 2026, Ganguly et al., 2024, Song et al., 19 Jul 2025).